Europe GMP Approval of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana.

Shilpa Medicare Limited, Unit 4, Jadcherla; Telangana, India was inspected by AGES, Austria from 22 January, 2024 until 26 January, 2024.

Following a successful inspection, the Unit has been issued GMP Certification from Ages, Austria.

The previous EU - GMP inspection for this facility was in January 2020.

This Unit of Shilpa Medicare is engaged in the manufacture, testing and distribution of sterile Injections and non-sterile tablets and Capsule finished dosage forms in the US, Europe and rest of the world markets. This inspection will facilitate continued supply of medicines for commercial distribution to various countries of the European Union from this Unit.

Shares of Shilpa Medicare Limited was last trading in BSE at Rs. 540.45 as compared to the previous close of Rs. 509.20. The total number of shares traded during the day was 89130 in over 3851 trades.

The stock hit an intraday high of Rs. 544.20 and intraday low of 502.25. The net turnover during the day was Rs. 46969928.00.

Source : Equity Bulls

Keywords

ShilpaMedicare INE790G01031 Europe GMP Approval Jadcherla Unit4